Synapse
⌘+K
Synapse
PulseExploreClubsResearchersJournals
Instagram
HomeClubsExplore
January 1, 1997Journal of Clinical OncologyOpen Access

Pharmacokinetics of paclitaxel and carboplatin in a dose-escalating and dose-sequencing study in patients with non-small-cell lung cancer. The European Cancer Centre.

View Full Paper
Ask AI
Bookmark
Share

Authors

MHManon HuizingUniversity of Antwerp
Giuseppe Giaccone
Giuseppe GiacconeAstraZeneca (United Kingdom)LWLaurence J. van WarmerdamEindhoven Cancer Registry

Discussion

Loading...

Member takes

Implication

Key Points

Key points are not available for this paper at this time.

Cite This Study

Huizing et al. (1997) studied this question.

synapsesocial.com/papers/6a7271d05d37378ac1df38afhttps://doi.org/10.1200/jco.1997.15.1.317
View Full Paper
Ask AI
Bookmark
Share

Also Consider

Synapse has enriched 3 closely related papers on similar clinical questions. Consider them for comparative context:

  1. 1Sequences of taxol and cisplatin: a phase I and pharmacologic study.1991 · 430 citations
  2. 2Combination chemotherapy versus single agents followed by combination chemotherapy in stage IV non-small-cell lung cancer: a study of the Eastern Cooperative Oncology Group.1989 · 323 citations
  3. 3European-Canadian randomized trial of paclitaxel in relapsed ovarian cancer: high-dose versus low-dose and long versus short infusion.1994 · 638 citations